Other Brands/Names

Atrovent, Combivent, Ipratropy Bromide, Lasalcom, and Midatro

How To Work

Ipratropy works by inhibiting muskarinik (M3) receptors in the airways. This drug is an anti-collinergic group that prevents acetylcolin from triggering the narrowing of the innocent bronkus muscles.

By inhibiting these signals, the bronkus muscles become more relaxed so that the airways widen. This widening effect of the airways helps increase air flow to the lungs and reduce shortness of breath, especially in COPD or asthma sufferers.

Indications

Ipratropy is indicated primarily to relieve bronospasme in COPD (Pronic Obstructive Lung Disease) conditions, including chronic and emphysema bronchitis. This drug can also be used as additional therapy for asthma, especially if the response to other fast work browsers is less than optimal. In the form of nasal sprays, ipratropy is indicated to reduce the rinore (watery nose) in allergic or nonalergy rinitis.

Contraindication

Ipratropy is contrasted to patients who have allergies or hypersensitivity to ipratropicium, atropines, or similar compounds of the anti-collinergic class. Patients with such conditions Narrow angle glaukoma or urine retention disorder need to use this drug carefully.

Side Effects

Ipratropic side effects are usually mild and appear due to their anti-oclinergy. Patients can experience dry mouth or throat, cough, nasal irritation, and headaches. Some patients may feel dizzy, nausea, or discomfort in the chest. If the drug is exposed to the eye, especially the shape of the inhalation, it can cause blurred or worsening vision of narrow angle glaukuma. Although rare, allergic reactions such as rashes or shortness of breath can also occur.

Ready

Ipratropy is available in several forms of preparation adapted to therapeutic needs. The most common form is Badminton aerosol to relieve the narrowing of the respiratory tract quickly. In addition, this drug is also present as a solution for nebulizer, which is inhaled using a nebulization device, as well as a nasal spray (nasal spray) which is used to reduce aqueous nose-like symptoms in rinitis. These various forms of preparation allow adjustments to the administration of drugs according to the patient's condition.

Dose

The dose of ipratropy varies depending on the form of preparation and the condition of the patient. For Badminton aerosol, usually given 2 sprays 3-4 times a day, while for solutions nebulizer, the general dose is 0.5 mg 3'4 times a day. In the form of nasal spray, the commonly used dose is 1.2 sprays in each nostril 2'3 times a day. The dose can be adjusted by the doctor based on the patient's response and the severity of the symptoms.

Security

Ipratropy is included in the category of B pregnancy according to the FDA, meaning studies in animals do not show any risk to the fetus, but there is not enough controlled data on pregnant women.

This drug is relatively safe to use during pregnancy and breastfeeding if used as recommended, because its systemic absorption is low. However, its use must still be under the supervision of doctors to ensure safety for mothers and babies.

Drug Interaction

Ipratropy generally has minimal drug interactions due to low systemic absorption. However, usage at the same time as other anti-oclinergaric drugs can increase the possibility of side effects such as dry mouth, constipation, or difficulty urinating.

Patients with narrow angle glaukuma or urine retention problems need to be careful, because ipratropy can worsen these conditions if combined with certain drugs.

Want to know information about other drugs? Check here, yes!